Omnicell Inc (FRA:OC9)
€ 41.8 -0.8 (-1.88%) Market Cap: 1.96 Bil Enterprise Value: 1.99 Bil PE Ratio: 0 PB Ratio: 1.66 GF Score: 74/100

Omnicell Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2021 / 07:40PM GMT
Release Date Price: €156 (-0.64%)
Adam Evan Heussner;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. We can go ahead and get started. Hello, everyone. I'm Adam Heussner, part of the technology -- part of the health care technology and distribution team here at Credit Suisse. Thanks, everyone, for joining us.

Next up, we have Peter Kuipers, Executive VP and CFO; and Kathleen Nemeth, VP of IR from Omnicell. A way of background, Omnicell is a leading provider of solutions targeting patient safety and operational efficiency in health care facilities. Peter joined Omnicell in 2015 as Executive VP and CFO.

Peter is going to begin with a quick presentation, and then we can open the line for Q&A. But with that, Peter, over to you.

Peter J. Kuipers
Omnicell, Inc. - Executive VP & CFO

Yes. Thank you, Adam. I thought what we would do is we'll give an overview of the company's strategy, our platform offering and our go-to-market approach and momentum that we have. This is a presentation that's available publicly on our website as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot